Skip to main content
5.0 on Google
← All medications
Appeal guide · Anti-CD20 therapy

Kesimpta denied by insurance? Appeal and win.

Kesimpta denials for multiple sclerosis usually involve step therapy through a preferred disease-modifying therapy or undocumented relapse history. A neurologist-supported appeal resolves most.

Start your appeal · $0 upfront No upfront cost. We build and file it for you.

Reviewed by the Apellica Appeals Team · Updated June 2026

We file appeals against every major U.S. carrier
UnitedHealthcare
Aetna
Cigna
Humana
Anthem (Elevance Health)
BlueCross BlueShield
Centene
Molina Healthcare
WellCare
Highmark
Kaiser Permanente
CVS Caremark
Medicare
Tricare
HCSC
Florida Blue
Health Net
Oscar Health
Clover Health
EmblemHealth
Premera Blue Cross
Regence
Geisinger
HealthPartners
Point32Health
AmeriHealth
UPMC Health Plan
CareSource
AvMed
Veterans Affairs
UnitedHealthcare
Aetna
Cigna
Humana
Anthem (Elevance Health)
BlueCross BlueShield
Centene
Molina Healthcare
WellCare
Highmark
Kaiser Permanente
CVS Caremark
Medicare
Tricare
HCSC
Florida Blue
Health Net
Oscar Health
Clover Health
EmblemHealth
Premera Blue Cross
Regence
Geisinger
HealthPartners
Point32Health
AmeriHealth
UPMC Health Plan
CareSource
AvMed
Veterans Affairs

Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.

Approved uses

Relapsing forms of multiple sclerosis.

Why Kesimpta gets denied

  • Step therapy through a preferred MS disease-modifying therapy
  • Prior-authorization criteria not documented
  • MS diagnosis or relapse history not evidenced
  • Non-formulary placement

What a winning appeal includes

  • Confirmed relapsing MS diagnosis with imaging and relapse history
  • Prior disease-modifying therapies and outcomes
  • Neurologist support
  • A letter of medical necessity mapped to criteria

How we approach the appeal

Document the MS diagnosis, relapse history, and prior-therapy outcomes, and request an override where step therapy is the basis.

Kesimpta appeal letter template

Copy this Kesimpta appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns Anti-CD20 therapy denials.

[Date]

[Your name]  ·  Member ID [ID]  ·  Rx claim # [#]
[Insurer or PBM] - Appeals Department

Re: Appeal of Kesimpta denial

I am appealing the denial of Kesimpta (ofatumumab). I request that the denial be overturned and Kesimpta approved.

1. The denial. [Insurer] denied Kesimpta stating, verbatim: "[paste the exact denial reason from your letter]."

2. Medical necessity. Kesimpta is medically necessary for my condition. Document the MS diagnosis, relapse history, and prior-therapy outcomes, and request an override where step therapy is the basis.

3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception.

4. My request. Approve Kesimpta within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions.

Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes.

Sincerely,
[Your name]

Want it built and filed for you? Use the free generator, or have Apellica do it.

Filing window

Internal appeals: 30 days pre-service, 60 days post-service, 72 hours urgent. File within 180 days.

Cost to start

$0 upfront. We assess fit first, then build and file the appeal for you.

Documents we'll ask for
  • · The denial letter and your Explanation of Benefits (EOB)
  • · Insurance ID, plan name, and the claim or prior-authorization number
  • · Diagnosis with ICD-10 code and the prescriber's clinical notes
  • · A record of treatments already tried and how they worked

Appealing a Kesimpta denial by insurer

The path depends on who manages your benefit. The most common:

CVS Caremark · PBM

Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.

Express Scripts · PBM

Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.

OptumRx · PBM

Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.

Aetna · Insurer

Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.

UnitedHealthcare · Insurer

Internal appeals and external review; pharmacy denials often route through OptumRx criteria.

Blue Cross Blue Shield · Insurer

Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.

Frequently asked questions

Why was Kesimpta denied?

Usually a step-therapy requirement or undocumented relapse history. Neurologist documentation of the diagnosis and prior therapies is key.

Kesimpta denied? We fight it for you.

$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.

Start Your Appeal

This page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.

Get started today

Send the denial. We'll take it from here.

$0 to start. Ten percent only if we win. No card at intake. A senior reviewer reads your denial letter within 24 hours, then we prepare the appeal, file it with the carrier, and chase the decision. One fee, ten percent of whatever the carrier pays you, and nothing if we do not recover.

Start Free Case Review